Inimmune Begins Phase 2 Trial of INI-2004 for Allergic Rhinitis
The randomised, placebo-controlled allergen chamber study will evaluate the safety and efficacy of Inimmune’s immunotherapy candidate INI-2004 in patients exposed to controlled ragweed allergens.
Allergic Rhinitis Treatment | 08/01/2026 | By News Bureau
Cadila Pharmaceuticals Introduces Dlorfast-M Tablets to Treat Allergic Rhinitis and Urticaria
Allergic rhinitis and urticaria are chronic health conditions that affect millions of people globally. Cadila Pharmaceuticals has introduced Dlorfast-M as a dual-action therapy targeting two pathways of the allergic response—histamine and leukotriene—aiming to provide wider and more effective symptom management.
Allergic Rhinitis Treatment | 14/10/2025 | By Dineshwori | 158
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy